PMC:7784824 / 857-1228 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":327,"end":337},"obj":"Species"},{"id":"24","span":{"begin":215,"end":223},"obj":"Disease"},{"id":"25","span":{"begin":266,"end":274},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:2697049"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:C000657245"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ted using 14 commercial assays. Additionally, 10 pre-pandemic sera and 9 potentially cross-reactive sera were selected. We calculated sensitivity and specificity. Furthermore, we discuss the diagnostic relevance of COVID-19 serology in a retrospective cohort of 145 COVID-19 cases in which repetitive molecular and serological SARS-CoV-2 tests were applied.\nResults: The "}

{"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":32,"end":119},"obj":"Sentence"},{"id":"T17","span":{"begin":120,"end":162},"obj":"Sentence"},{"id":"T18","span":{"begin":163,"end":357},"obj":"Sentence"},{"id":"T19","span":{"begin":358,"end":366},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ted using 14 commercial assays. Additionally, 10 pre-pandemic sera and 9 potentially cross-reactive sera were selected. We calculated sensitivity and specificity. Furthermore, we discuss the diagnostic relevance of COVID-19 serology in a retrospective cohort of 145 COVID-19 cases in which repetitive molecular and serological SARS-CoV-2 tests were applied.\nResults: The "}